Title:
ＰＤ－１アゴニスト抗体およびその使用
Document Type and Number:
Japanese Patent JP7259107
Kind Code:
B2
Abstract:
The present invention relates to anti-human PD-1 agonist antibodies, and uses thereof for treating autoimmune disorders such as rheumatoid arthritis or for decreasing rejection of transplanted cells and/or tissues.
Inventors:
Choi, Chin
Fen, Ekin
New Bern, Christine Page
Truer, Stephanie Marie
Verdino, Petra
Yachi, Pier Paulina
Fen, Ekin
New Bern, Christine Page
Truer, Stephanie Marie
Verdino, Petra
Yachi, Pier Paulina
Application Number:
JP2022034413A
Publication Date:
April 17, 2023
Filing Date:
March 07, 2022
Export Citation:
Assignee:
Eli Lilly and Company
International Classes:
C07K16/28; A61K39/395; A61K45/00; A61P1/04; A61P1/16; A61P1/18; A61P5/18; A61P7/06; A61P9/00; A61P9/10; A61P11/02; A61P11/06; A61P15/00; A61P17/00; A61P21/00; A61P21/04; A61P29/00; A61P31/12; A61P37/06; A61P37/08; C07K16/46; C07K19/00
Foreign References:
| WO2017058859A1 | ||||
| WO2016020856A2 | ||||
| WO2011110621A1 | ||||
| EP2742953A1 |
Attorney, Agent or Firm:
Hiroshi Kobayashi
Norio Omori
Ueda Wataru
Norio Omori
Ueda Wataru